pipette
ESEspañol

Intracellular complement Factor B couples inflammatory sensing to metabolism, chromatin regulation and maladaptive tissue repair

T. Freiwald, D. Chauss, M. Tajmul, J. L. Trujillo-Ochoa, D. Kumar, J. Ma, M. Snyder, N. Cheru, J. F. Jaeger, Y. Zhuang, J. B. Gregor, G. Ganne, L. Wang, Y. Guo, M. Gunkel, T. Huber, T. Wiech, E. E. West, S. Ayyadevara, M. Kolev, S. Briggs, C. Kemper, M. Kazemian, D. Portilla, B. Afzali

Preprint

In the authors' words

Inflammatory signals are broadly conserved, yet how tissue context converts them into programs of recovery or maladaptive repair remains unclear. Using kidney injury as a model of inflammation-to-repair transitions, we identify an injury-induced proximal-tubule complement program in which cell-intrinsic complement proteins are repurposed across subcellular compartments to couple inflammation to metabolic and chromatin regulation and promote maladaptive fibrotic remodeling. Mechanistically, myeloid-derived IL-1b; signals through IL-1R1 on injured tubular cells to recruit NF-kB and AP-1 to C3 and Cfb, coordinately inducing complement component 3 (C3) and Factor B (FB). Cytoplasmic FB drives cleavage-activation of cell-intrinsic C3, which supports tubular cell mitochondrial metabolic adaptation to stress and accumulation of C3aR-expressing macrophages around injured tubules. Nuclear FB, on the other hand, binds chromatin through a previously unrecognized DNA-binding interface and mediates histone H3 proteolysis and the preferential remodeling of chromatin promotors enriched in transcriptional programs relevant to maladaptive repair. Key features of this injury-associated C3-FB response, including intranuclear FB, are conserved in human kidney disease, associate with kidney dysfunction, and distinguish diseased from healthy kidneys. Together, these findings suggest that extracellular complement-targeting therapies may miss disease-relevant intracellular functions and suggest nuclear FB as a distinct target whose chromatin interaction and processing capacity could selectively limit maladaptive tissue responses beyond conventional inhibition.

Main resultThe abstract does not state a limitation.

Appeared: Monday, October 12. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.04.756581